2020 Revenues ($USD) : $26,617,000,000
2020 R&D spend : $5,991,000,000
2020 Number of Employees : 76,100
Fiscal Year End : 12/31/2020
Key People : Pascal Soriot, CEO; Marc Dunoyer, CFO; Katarina Ageborg, EVP, sustainability and chief compliance officer, president of AstraZeneca AB Sweden; Pam Cheng, EVP, operations and information technology; Ruud Dobber, EVP, BioPharmaceuticals business unit; David Fredrickson, EVP, Oncology business unit; Menelas (Mene) Pangalos, EVP, BioPharmaceuticals R&D; Jeff Pott, EVP, human resources and general counsel; Iskra Reic, EVP, Europe and Canada; Leon Wang, EVP, international

[An AstraZeneca scientist reviews compounds. Image courtesy of AstraZeneca.]